Autoimmune lymphoproliferative syndrome secondary prevention

Autoimmune lymphoproliferative syndrome Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Autoimmune lymphoproliferative syndrome secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune lymphoproliferative syndrome secondary prevention
CDC on Autoimmune lymphoproliferative syndrome secondary prevention
Autoimmune lymphoproliferative syndrome secondary prevention in the news
Blogs on Autoimmune lymphoproliferative syndrome secondary prevention
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S

Overview

There is no established secondary prevention method for ALPS. But regular monitoring for lymphoma and proper vaccination for the patients requiring splenectomy might be helpful.

Secondary Prevention

Individuals who require to get splenectomy should be vaccinated and have penicillin prophylaxis to prevent the complications.